Results 231 to 240 of about 1,054,375 (301)

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.

Journal of Urology, 1985
C. Sternberg, C. Sternberg, C. Sternberg, A. Yagoda, A. Yagoda, A. Yagoda, H. Scher, H. Scher, H. Scher, R. Watson, R. Watson, R. Watson, T. Ahmed, T. Ahmed, T. Ahmed, L. Weiselberg, L. Weiselberg, L. Weiselberg, N. Geller, N. Geller, N. Geller, P. Hollander, P. Hollander, P. Hollander, H. Herr, H. Herr, H. Herr, P. Sogani, P. Sogani, P. Sogani, M. Morse, M. Morse, M. Morse, W. Whitmore, W. Whitmore, W. Whitmore   +35 more
semanticscholar   +1 more source

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

Journal of Clinical Oncology, 1999
D. Bajorin, P. M. Dodd, Madhu Mazumdar, M. Fazzari, J. McCaffrey, H. Scher, H. Herr, G. Higgins, M. Boyle   +8 more
semanticscholar   +1 more source

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Urology, 1998
M. Hall, Sean Womack, A. Sagalowsky, T. Carmody, Mark D Erickstad, C. Roehrborn   +5 more
semanticscholar   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Journal of Urology, 1988
C. Sternberg, C. Sternberg, A. Yagoda, A. Yagoda, H. Scher, H. Scher, R. Watson, R. Watson, H. Herr, H. Herr, M. Morse, M. Morse, P. Sogani, P. Sogani, E. Vaughan, E. Vaughan, N. Bander, N. Bander, L. Weiselberg, L. Weiselberg, N. Geller, N. Geller, P. Hollander, P. Hollander, R. Lipperman, R. Lipperman, W. Fair, W. Fair, W. Whitmore, W. Whitmore   +29 more
semanticscholar   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.

Journal of Clinical Oncology, 2010
J. Bellmunt, T. Choueiri, R. Fougeray, F. Schutz, Y. Salhi, E. Winquist, S. Culine, H. von der Maase, D. Vaughn, J. Rosenberg   +9 more
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis.

Journal of Urology, 1977
P. Schellhammer, M. Bean, W. Whitmore
semanticscholar   +1 more source

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly